Genentech/Biogen Idec Second Generation Anti-CD20 Marriage May Be On The Rocks
This article was originally published in The Pink Sheet Daily
Executive Summary
Dispute over rights to second generation anti-CD20 molecules could have a negative impact on development timelines, Genentech says.